Get started
Award

101070950

Funded outputs count: 6
Funder award ID: 101070950
OpenAlex ID: G1677613914
Therapeutic inhibition of telomeric DNA damage response rescues hematopoietic dysfunction driven by telomere shortening and aging
2026 · Alessia Oppezzo, Sara Sepe, et al. · Nature Aging · 3
PDF
Selection of human hematopoietic stem cells bearing the intended functional edit by transient AND-gate reporters
2026 · Daniele Canarutto, Martina Fiumara, et al. · Nature Biotechnology · 5
Ex vivo expansion of hematopoietic stem and progenitor cells from human mobilized peripheral blood for gene therapy applications
2026 · Erika Zonari, Matteo Maria Naldini, et al. · Molecular Therapy · 1
Nanoengineered 3D culture substrate enables superior persistence and polyclonal engraftment of genetically engineered hematopoietic stem cells
2026 · Federico Midena, Laura Alessandrini, et al. · Cell stem cell · 3
Senescence and inflammation are unintended adverse consequences of CRISPR-Cas9/AAV6-mediated gene editing in hematopoietic stem cells
2025 · Anastasia Conti, Kety Giannetti, et al. · Cell Reports Medicine · 19
PDF
A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
2024 · Lucrezia della Volpe, Federico Midena, et al. · Cell Reports Medicine · 24
Year
Topic